Welcome to LookChem.com Sign In|Join Free

CAS

  • or

126-00-1

Post Buying Request

126-00-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

126-00-1 Usage

Chemical Properties

Light pink solid

Uses

Different sources of media describe the Uses of 126-00-1 differently. You can refer to the following data:
1. Diphenolic acid (DPA) has been identified as a potential replacement for bisphenol A, which is one of the monomers for epoxy resins and polycarbonates. DPA also can Intermediate for surface coatings, lubricating oil additives, cosmetics, surfactants, plasticizers, textile chemicals.
2. Diphenolic Acid is a flux compound. Adhesives for semiconductor devices.
3. Since diphenolic acid is a close structural analog of bisphenol A, diphenolic acid has the potential to displace bisphenol A. A possible endocrine disruptor, bisphenol A is used in polymer applications such as for use in baby bottles, dental resins, and lacquers to coat food cans.

Preparation

Diphenolic acid (DPA) can be made by the condensation reaction of levulinic acid with phenol in the presence of acid catalysts. Synthesis of diphenolic acid from levulinic acid

Industrial uses

Diphenolic acid, the condensation product of levulinic acid and phenol, is useful in the preparation of the modified phenol formaldehyde resins, polyether resins and as monocarboxilic acid chain stopper in alkyd resin (Bader, 1960).

Purification Methods

When recrystallised from *C6H6, the crystals have 0.5 mol of *C6H6 (m 120-122o), and when recrystallised from toluene, the crystals have 0.5 mol of toluene. Purify the acid by recrystallisation from hot H2O. It is soluble in Me2CO, AcOH, EtOH, propan-2-ol, methyl ethyl ketone. It can also be recrystallised from AcOH, heptane/Et2O or Me2CO/*C6H6. It has max 225 and 279nm in EtOH. The methyl ester has m 87-89o (aqueous MeOH to give the trihydrate). [Bader & Kantowicz J Am Chem Soc 76 4465 1954, Beilstein 10 IV 1890.]

Check Digit Verification of cas no

The CAS Registry Mumber 126-00-1 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,2 and 6 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 126-00:
(5*1)+(4*2)+(3*6)+(2*0)+(1*0)=31
31 % 10 = 1
So 126-00-1 is a valid CAS Registry Number.
InChI:InChI=1/C17H14Br4O4/c1-17(3-2-14(22)23,8-4-10(18)15(24)11(19)5-8)9-6-12(20)16(25)13(21)7-9/h4-7,24-25H,2-3H2,1H3,(H,22,23)

126-00-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (L14338)  4,4-Bis(4-hydroxyphenyl)valeric acid, 97%   

  • 126-00-1

  • 100g

  • 193.0CNY

  • Detail
  • Alfa Aesar

  • (L14338)  4,4-Bis(4-hydroxyphenyl)valeric acid, 97%   

  • 126-00-1

  • 500g

  • 625.0CNY

  • Detail

126-00-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name Diphenolic Acid

1.2 Other means of identification

Product number -
Other names Diphenolic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:126-00-1 SDS

126-00-1Synthetic route

levulinic acid
123-76-2

levulinic acid

phenol
108-95-2

phenol

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

Conditions
ConditionsYield
With sulfuric acid
With hydrogenchloride
With C16H28N4O6S2(2+)*2CF3O3S(1-); C16H28N4O6S2(2+)*2C3H7O3S2(1-) at 60℃; for 48h; Reagent/catalyst; Sealed tube; Inert atmosphere; Schlenk technique;91 mol
4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl-benzenebutanoic acid methyl ester
7297-85-0

4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl-benzenebutanoic acid methyl ester

methyl iodide
74-88-4

methyl iodide

A

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

B

4,4-bis(4'-methoxyphenyl)pentanoic acid
111161-78-5

4,4-bis(4'-methoxyphenyl)pentanoic acid

C

(4'-hydroxyphenyl)-4-(4''-methoxyphenyl)pentanoic acid

(4'-hydroxyphenyl)-4-(4''-methoxyphenyl)pentanoic acid

Conditions
ConditionsYield
With potassium hydroxide; cobalt(II) acetate; silver(l) oxide Product distribution; multistepreaction, degradative method for the determination of the degree of branching for hyperbranched macromolecules;
water
7732-18-5

water

levulinic acid
123-76-2

levulinic acid

phenol
108-95-2

phenol

mineral acid

mineral acid

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

4-oxopentanoic acid ethyl ester
539-88-8

4-oxopentanoic acid ethyl ester

phenol
108-95-2

phenol

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

Conditions
ConditionsYield
With sulfuric acid In water at 0 - 20℃; for 18h; Condensation;
levulinic acid
123-76-2

levulinic acid

phenol
108-95-2

phenol

A

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

B

C17H18O4
1033556-25-0

C17H18O4

Conditions
ConditionsYield
With ethanethiol at 99.84℃; for 16h; Inert atmosphere;
With C16H28N4O6S2(2+)*2C3H7O3S2(1-) at 60℃; for 48h; Reagent/catalyst; Temperature; Time; Concentration; Sealed tube; Inert atmosphere; Schlenk technique; Overall yield = 75 mol;
4-oxopentanoic acid ethyl ester
539-88-8

4-oxopentanoic acid ethyl ester

phenol
108-95-2

phenol

A

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

B

ethyl diphenolate
7297-86-1

ethyl diphenolate

Conditions
ConditionsYield
With C16H28N4O6S2(2+)*2CF3O3S(1-); C16H28N4O6S2(2+)*2C3H7O3S2(1-) at 60℃; for 48h; Reagent/catalyst; Sealed tube; Inert atmosphere; Schlenk technique; Overall yield = 80 mol;A 22 mol
B 58 mol
levulinic acid methyl ester
624-45-3

levulinic acid methyl ester

phenol
108-95-2

phenol

A

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

B

4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl-benzenebutanoic acid methyl ester
7297-85-0

4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl-benzenebutanoic acid methyl ester

Conditions
ConditionsYield
With C16H28N4O6S2(2+)*2CF3O3S(1-); C16H28N4O6S2(2+)*2C3H7O3S2(1-) at 60℃; for 48h; Sealed tube; Inert atmosphere; Schlenk technique; Overall yield = 79 mol;A 22 mol
B 57 mol
butyl levulinate
2052-15-5

butyl levulinate

phenol
108-95-2

phenol

A

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

B

butyl diphenolate
7297-88-3

butyl diphenolate

Conditions
ConditionsYield
With C16H28N4O6S2(2+)*2CF3O3S(1-); C16H28N4O6S2(2+)*2C3H7O3S2(1-) at 60℃; for 48h; Sealed tube; Inert atmosphere; Schlenk technique; Overall yield = 81 mol;A 16 mol
B 65 mol
methanol
67-56-1

methanol

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl-benzenebutanoic acid methyl ester
7297-85-0

4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl-benzenebutanoic acid methyl ester

Conditions
ConditionsYield
With sulfuric acid for 8h; Fischer-Speier Esterification; Reflux;99%
With sulfuric acid for 3h; Esterification; Heating;97%
for 2h; Reflux;96%
methanol
67-56-1

methanol

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

trimethyl orthoformate
149-73-5

trimethyl orthoformate

4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl-benzenebutanoic acid methyl ester
7297-85-0

4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl-benzenebutanoic acid methyl ester

Conditions
ConditionsYield
With p-toluenesulfonic acid monohydrate for 16h; Reflux;98%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

trimethyl orthoformate
149-73-5

trimethyl orthoformate

4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl-benzenebutanoic acid methyl ester
7297-85-0

4-hydroxy-γ-(4-hydroxyphenyl)-γ-methyl-benzenebutanoic acid methyl ester

Conditions
ConditionsYield
With toluene-4-sulfonic acid In methanol for 16h; Reflux;98%
formaldehyd
50-00-0

formaldehyd

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

1,3,5-triphenylhexahydro-1,3,5-triazine
91-78-1

1,3,5-triphenylhexahydro-1,3,5-triazine

4,4-bis[3-phenyl-3,4-dihydro-2H-1,3-benzoxazin-6-yl]pentanoic acid
918303-70-5

4,4-bis[3-phenyl-3,4-dihydro-2H-1,3-benzoxazin-6-yl]pentanoic acid

Conditions
ConditionsYield
In toluene at 110℃; for 6h;95%
In toluene at 110℃; for 6h;94.8%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

phosphazene base-P4-tert-butyl
111324-04-0

phosphazene base-P4-tert-butyl

C17H18O4*C22H63N13P4
1370263-33-4

C17H18O4*C22H63N13P4

Conditions
ConditionsYield
In tetrahydrofuran; hexane at 20℃; for 12h; Inert atmosphere;95%
1-methyl-piperazine
109-01-3

1-methyl-piperazine

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

N-methyl piperazine diphenolamide

N-methyl piperazine diphenolamide

Conditions
ConditionsYield
at 160 - 180℃; Inert atmosphere;95%
at 80 - 180℃; Inert atmosphere;85%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

benzyl chloride
100-44-7

benzyl chloride

benzyl 4,4-bis[4-(benzyloxy)phenyl]pentanoate
184866-14-6

benzyl 4,4-bis[4-(benzyloxy)phenyl]pentanoate

Conditions
ConditionsYield
With 18-crown-6 ether; potassium carbonate In acetone for 72h; Heating;90%
ethanol
64-17-5

ethanol

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

ethyl diphenolate
7297-86-1

ethyl diphenolate

Conditions
ConditionsYield
With sulfuric acid for 16h; Fischer-Speier Esterification; Reflux;85%
at 40℃; for 8h; Sealed tube; Inert atmosphere; Schlenk technique;83 mol
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

9-bromoethylanthracene
2417-77-8

9-bromoethylanthracene

anthracen-9-ylmethyl-4,4-bis(4-hydroxyphenyl)pentanoate

anthracen-9-ylmethyl-4,4-bis(4-hydroxyphenyl)pentanoate

Conditions
ConditionsYield
Stage #1: 4,4-bis(4-hydroxyphenyl)valeric acid With potassium hydrogencarbonate In N,N-dimethyl-formamide at 80℃; for 0.5h;
Stage #2: 9-bromoethylanthracene In N,N-dimethyl-formamide at 80℃; for 2h;
84%
anthracenylmethyl chloride
24463-19-2

anthracenylmethyl chloride

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

anthracen-9-ylmethyl-4,4-bis(4-hydroxyphenyl)pentanoate

anthracen-9-ylmethyl-4,4-bis(4-hydroxyphenyl)pentanoate

Conditions
ConditionsYield
Stage #1: 4,4-bis(4-hydroxyphenyl)valeric acid With potassium hydrogencarbonate In N,N-dimethyl-formamide at 80℃; for 0.5h;
Stage #2: anthracenylmethyl chloride In N,N-dimethyl-formamide at 80℃; for 5h;
84%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

benzyl bromide
100-39-0

benzyl bromide

benzyl 4,4-bis[4-(benzyloxy)phenyl]pentanoate
184866-14-6

benzyl 4,4-bis[4-(benzyloxy)phenyl]pentanoate

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In acetone Reflux;83.5%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

(9H-fluoren-9-yl)methyl (S)-(2-amino-3-((3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)(methyl)amino)-3-oxopropyl)carbamate

(9H-fluoren-9-yl)methyl (S)-(2-amino-3-((3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)(methyl)amino)-3-oxopropyl)carbamate

(9H-fluoren-9-yl)methyl (S)-(2-(4,4-bis(4-hydroxyphenyl)pentanamido)-3-((3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)(methyl)amino)-3-oxopropyl)carbamate

(9H-fluoren-9-yl)methyl (S)-(2-(4,4-bis(4-hydroxyphenyl)pentanamido)-3-((3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)(methyl)amino)-3-oxopropyl)carbamate

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 1h;83%
2-bromoisobutyric acid bromide
20769-85-1

2-bromoisobutyric acid bromide

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

4,4-bis-[4-(2-bromo-2-methyl-propionyloxy)-phenyl]-pentanoic acid

4,4-bis-[4-(2-bromo-2-methyl-propionyloxy)-phenyl]-pentanoic acid

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran for 48h;82%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

desipramine hydrochloride
58-28-6

desipramine hydrochloride

N-(3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)-4,4-bis(4-hydroxyphenyl)-N-methylpentanamide

N-(3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)-4,4-bis(4-hydroxyphenyl)-N-methylpentanamide

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 1h;82%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

4-(hydroxymethyl)-1-oxido-2,6,7-trioxa-1-phosphabicyclo [2.2.2] octane
5301-78-0

4-(hydroxymethyl)-1-oxido-2,6,7-trioxa-1-phosphabicyclo [2.2.2] octane

C22H25O8P

C22H25O8P

Conditions
ConditionsYield
With toluene-4-sulfonic acid In acetonitrile at 70℃; for 24h; Inert atmosphere;80.2%
With toluene-4-sulfonic acid In acetonitrile for 24h; Inert atmosphere; Reflux;55%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

ethyl 3-endo-3-hydroxy-8-azabicyclo[3.3.1]octane-8-carboxylate
30833-12-6

ethyl 3-endo-3-hydroxy-8-azabicyclo[3.3.1]octane-8-carboxylate

N-ethoxycarbonyl diphenylglycol acetate

N-ethoxycarbonyl diphenylglycol acetate

Conditions
ConditionsYield
Stage #1: 4,4-bis(4-hydroxyphenyl)valeric acid With dmap; dicyclohexyl-carbodiimide In dichloromethane at 0 - 30℃; for 2.5h;
Stage #2: ethyl 3-endo-3-hydroxy-8-azabicyclo[3.3.1]octane-8-carboxylate With dmap In dichloromethane at 25 - 30℃; for 3.5h;
80%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

tert-butyl alcohol
75-65-0

tert-butyl alcohol

tert-butyl 4,4-bis(4'-hydroxyphenyl)pentanoate
138721-52-5

tert-butyl 4,4-bis(4'-hydroxyphenyl)pentanoate

Conditions
ConditionsYield
Stage #1: 4,4-bis(4-hydroxyphenyl)valeric acid With trifluoroacetic anhydride In tetrahydrofuran at 5 - 20℃; for 2.5h;
Stage #2: tert-butyl alcohol In tetrahydrofuran at 20℃; for 6h;
71.1%
tetrakis[bis(trimethylsilyl)methyl]digallane(4)
125370-09-4

tetrakis[bis(trimethylsilyl)methyl]digallane(4)

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

Ga2(CH(SiMe3)2)2(4,4-bis(4-hydroxyphenyl)valerate)2
1258211-74-3

Ga2(CH(SiMe3)2)2(4,4-bis(4-hydroxyphenyl)valerate)2

Conditions
ConditionsYield
In tetrahydrofuran digallium compd. and acid suspended in THF at room temp.; suspn. stirred at room temp. for 16 h; volatiles removed in vacuo; residue washed with n-pentane;66%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

1,3-dibromo-propane
109-64-8

1,3-dibromo-propane

4,4-bis-(4-hydroxy-phenyl)-pentanoic acid 3-bromo-propyl ester
848599-31-5

4,4-bis-(4-hydroxy-phenyl)-pentanoic acid 3-bromo-propyl ester

Conditions
ConditionsYield
Stage #1: 4,4-bis(4-hydroxyphenyl)valeric acid With potassium hydrogencarbonate In N,N-dimethyl-formamide at 80℃; for 0.5h;
Stage #2: 1,3-dibromo-propane In N,N-dimethyl-formamide at 80℃; for 5h;
65%
3,4-dihydro-2H-pyran
110-87-2

3,4-dihydro-2H-pyran

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

4,4-bis-[4-(tetrahydro-pyran-2-yloxy)-phenyl]-pentanoic acid

4,4-bis-[4-(tetrahydro-pyran-2-yloxy)-phenyl]-pentanoic acid

Conditions
ConditionsYield
With pyridinium p-toluenesulfonate65%
methanol
67-56-1

methanol

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

2-(chloromethyl)quinoline monohydrochloride
3747-74-8

2-(chloromethyl)quinoline monohydrochloride

A

4,4-bis(3-chloro-4-(2-quinolylmethoxy)phenyl)pentanoic acid methyl ester
189498-99-5

4,4-bis(3-chloro-4-(2-quinolylmethoxy)phenyl)pentanoic acid methyl ester

B

4-(3-chloro-4-(2-quinolylmethoxy)phenyl)-4-(3,5-dichloro-4-(2-quinolylmethoxy)phenyl)pentanoic acid methyl ester

4-(3-chloro-4-(2-quinolylmethoxy)phenyl)-4-(3,5-dichloro-4-(2-quinolylmethoxy)phenyl)pentanoic acid methyl ester

Conditions
ConditionsYield
Stage #1: 4,4-bis(4-hydroxyphenyl)valeric acid With N-chloro-succinimide In 1,4-dioxane; chloroform for 5h; Chlorination; Heating;
Stage #2: methanol With thionyl chloride at 20℃; for 16h; Esterification;
Stage #3: 2-(chloromethyl)quinoline monohydrochloride With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 10h; Alkylation; Further stages.;
A 61%
B 9%
Diethyl iminodiacetate
6290-05-7

Diethyl iminodiacetate

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

{[4,4-bis-(4-hydroxyphenyl)-pentanoyl]-ethoxycarbonyl-methylamino}-acetic acid ethyl ester
625833-52-5

{[4,4-bis-(4-hydroxyphenyl)-pentanoyl]-ethoxycarbonyl-methylamino}-acetic acid ethyl ester

Conditions
ConditionsYield
With 2-chloro-1-methyl-pyridinium iodide; triethylamine In 1,4-dioxane at 70℃; for 0.166667 - 0.333333h;56%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

(9H-fluoren-9-yl)methyl (2-((3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)amino)ethyl)carbamate

(9H-fluoren-9-yl)methyl (2-((3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)amino)ethyl)carbamate

(9H-fluoren-9-yl)methyl (2-(N-(3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)-4,4-bis(4-hydroxyphenyl)pentanamido)ethyl)carbamate

(9H-fluoren-9-yl)methyl (2-(N-(3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl)-4,4-bis(4-hydroxyphenyl)pentanamido)ethyl)carbamate

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 1h;48%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

2-(3,4-bis((tert-butyldimethylsilyl)oxy)phenyl)ethan-1-amine
165749-18-8

2-(3,4-bis((tert-butyldimethylsilyl)oxy)phenyl)ethan-1-amine

N-(3,4-bis((tert-butyldimethylsilyl)oxy)phenethyl)-4,4-bis(4-hydroxyphenyl)pentanamide

N-(3,4-bis((tert-butyldimethylsilyl)oxy)phenethyl)-4,4-bis(4-hydroxyphenyl)pentanamide

Conditions
ConditionsYield
With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In ethyl acetate at 20℃; for 3h; Inert atmosphere;46%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

1,1'-carbonyldiimidazole
530-62-1

1,1'-carbonyldiimidazole

dibenzylamine
103-49-1

dibenzylamine

4,4-Bis-(4-hydroxyphenyl)pentanoic acid dibenzylamide
188108-07-8

4,4-Bis-(4-hydroxyphenyl)pentanoic acid dibenzylamide

Conditions
ConditionsYield
With hydrogenchloride In tetrahydrofuran; water; ethyl acetate40%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

C23H32O4Si
1219458-16-8

C23H32O4Si

Conditions
ConditionsYield
Stage #1: 4,4-bis(4-hydroxyphenyl)valeric acid; tert-butyldimethylsilyl chloride With 1H-imidazole In tetrahydrofuran for 12h; Reflux;
Stage #2: With acetic acid In water at 20℃; for 2h;
40%
6-azido-2S-{[(9H-fluorenyl-9-ylmethoxy)carbonyl]amino}hexanoic acid
159610-89-6

6-azido-2S-{[(9H-fluorenyl-9-ylmethoxy)carbonyl]amino}hexanoic acid

O-bis-(aminoethyl)ethylene glycol trityl resin

O-bis-(aminoethyl)ethylene glycol trityl resin

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)hex-5-ynamide
1623789-42-3

N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)hex-5-ynamide

Fmoc-Asp-O-t-Bu
129460-09-9, 134098-70-7

Fmoc-Asp-O-t-Bu

N-[4,4-bis(4-hydroxyphenyl)pentanoyl]-β-aspartyl-β-aspartyl-N-{2-[2-(2-aminoethoxy)ethoxy]ethyl}-6-(4-{4-oxo-4-[(5-sulfamoyl-1,3,4-thiadiazol-2-yl)amino]butyl}-1H-1,2,3-triazol-1-yl)-L-norleucinamide

N-[4,4-bis(4-hydroxyphenyl)pentanoyl]-β-aspartyl-β-aspartyl-N-{2-[2-(2-aminoethoxy)ethoxy]ethyl}-6-(4-{4-oxo-4-[(5-sulfamoyl-1,3,4-thiadiazol-2-yl)amino]butyl}-1H-1,2,3-triazol-1-yl)-L-norleucinamide

Conditions
ConditionsYield
Stage #1: 6-azido-2S-{[(9H-fluorenyl-9-ylmethoxy)carbonyl]amino}hexanoic acid; O-bis-(aminoethyl)ethylene glycol trityl resin With benzotriazol-1-ol; O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane; N,N-dimethyl-formamide at 22℃; for 1.25h; trityl resin;
Stage #2: With piperidine In N,N-dimethyl-formamide
Stage #3: 4,4-bis(4-hydroxyphenyl)valeric acid; N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)hex-5-ynamide; Fmoc-Asp-O-t-Bu Further stages;
38%
1-hydroxy-pyrrolidine-2,5-dione
6066-82-6

1-hydroxy-pyrrolidine-2,5-dione

4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

2,5-dioxopyrrolidin-1-yl-4,4-bis(4-hydroxyphenyl)pentanoate
1445510-01-9

2,5-dioxopyrrolidin-1-yl-4,4-bis(4-hydroxyphenyl)pentanoate

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In tetrahydrofuran at 20℃; for 22h;36%
With dmap; dicyclohexyl-carbodiimide In tetrahydrofuran at 20℃; for 1h;250 mg
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

Fmoc-Leu-OH
35661-60-0

Fmoc-Leu-OH

N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)hex-5-ynamide
1623789-42-3

N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)hex-5-ynamide

Boc-Lys(Fmoc)-OH
84624-27-1

Boc-Lys(Fmoc)-OH

Fmoc-(tBu)Asp-OH
71989-14-5

Fmoc-(tBu)Asp-OH

Fmoc-Asp-O-t-Bu
129460-09-9, 134098-70-7

Fmoc-Asp-O-t-Bu

N-(9-fluorenylmethoxycarbonyl)-S-trityl-L-cysteine
103213-32-7

N-(9-fluorenylmethoxycarbonyl)-S-trityl-L-cysteine

C52H70N14O19S3

C52H70N14O19S3

Conditions
ConditionsYield
Stage #1: N-(9-fluorenylmethoxycarbonyl)-S-trityl-L-cysteine With piperidine In N,N-dimethyl-formamide for 0.25h;
Stage #2: Fmoc-(tBu)Asp-OH With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 0℃; for 1.25h;
Stage #3: 4,4-bis(4-hydroxyphenyl)valeric acid; Fmoc-Leu-OH; N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)hex-5-ynamide; Boc-Lys(Fmoc)-OH; Fmoc-Asp-O-t-Bu Further stages;
22%
4,4-bis(4-hydroxyphenyl)valeric acid
126-00-1

4,4-bis(4-hydroxyphenyl)valeric acid

Fmoc-Leu-OH
35661-60-0

Fmoc-Leu-OH

5-hexynoic amide
21233-94-3

5-hexynoic amide

Fmoc-(tBu)Asp-OH
71989-14-5

Fmoc-(tBu)Asp-OH

Fmoc-Asp-O-t-Bu
129460-09-9, 134098-70-7

Fmoc-Asp-O-t-Bu

N-(9-fluorenylmethoxycarbonyl)-S-trityl-L-cysteine
103213-32-7

N-(9-fluorenylmethoxycarbonyl)-S-trityl-L-cysteine

Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine

Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine

NH2+-ValCit-MMAE

NH2+-ValCit-MMAE

Conditions
ConditionsYield
Stage #1: N-(9-fluorenylmethoxycarbonyl)-S-trityl-L-cysteine With piperidine In N,N-dimethyl-formamide for 0.25h;
Stage #2: Fmoc-(tBu)Asp-OH With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 0℃; for 1.25h;
Stage #3: 4,4-bis(4-hydroxyphenyl)valeric acid; Fmoc-Leu-OH; 5-hexynoic amide; Fmoc-Asp-O-t-Bu; Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine Further stages;
11%

126-00-1Related news

Mesoporous H3PW12O40-silica composite: Efficient and reusable solid acid catalyst for the synthesis of Diphenolic acid (cas 126-00-1) from levulinic acid09/29/2019

Mesoporous H3PW12O40-silica composite catalysts with controllable H3PW12O40 loadings (4.0–65.1%) were prepared by a direct sol–gel–hydrothermal technique in the presence of triblock poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) copolymer. Powder X-ray diffraction (XRD) patte...detailed

Thermal stability of aromatic polyesters prepared from Diphenolic acid (cas 126-00-1) and its esters09/27/2019

The thermal performance of aromatic polyesters (poly(DPA–IPC), poly(MDP–IPC) and poly(EDP–IPC)) prepared from isophthaloyl chloride (IPC) with diphenolic acid (DPA) and its esters were studied with DSC and TG, and the decomposition mechanism of poly(DPA–IPC) were investigated using FTIR and ...detailed

Treatment of water contaminated with Diphenolic acid (cas 126-00-1) by gamma radiation in the presence of different compounds09/26/2019

The elimination of diphenolic acid (DPA) from contaminated water is an urgent challenge. The aim of this study was to investigate DPA degradation by gamma radiation, studying the influence of the dose rate, initial DPA concentration, solution pH, the presence of O2, and the presence of different...detailed

Diphenolic acid (cas 126-00-1) based biphosphate on the properties of polylactic acid: Synthesis, fire behavior and flame retardant mechanism09/25/2019

In an effort to impart fire protection properties to polylactic acid (PLA) utilizing renewable resources, diphenolic acid, a plant derived compound, was used to synthesize a biphosphate (hereinafter shortened as FR) that contains two types of phosphorus. The chemical structure of FR was confirme...detailed

Self-foaming Diphenolic acid (cas 126-00-1) benzoxazine09/09/2019

This work concerns the investigation of porous polybenzoxazines based on the non-toxic renewable diphenolic acid. The approach described relies on the in situ generation of foaming agent (CO2) during the thermal curing. For this purpose, the previously synthesized benzoxazine monomer from diphen...detailed

126-00-1Relevant articles and documents

-

Bader,Kontowicz

, p. 4465 (1954)

-

Kinetics of phosphotungstic acid-catalyzed condensation of levulinic acid with phenol to diphenolic acid: Temperature-controlled regioselectivity

Evrard, Clint N.,Hossain, Md Anwar,Rahaman, Mohammad Shahinur,Sathitsuksanoh, Noppadon,Thompson, Lee M.,Tulaphol, Sarttrawut

, (2021/09/10)

Diphenolic acid (DPA) is a renewable compound to produce polycarbonates and epoxy resins. Diphenolic acid is produced by acid-catalyzed condensation of levulinic acid with phenol to form monophenolic acid. Subsequently, monophenolic acid undergoes condensation with phenol to form two DPA isomers, ortho-diphenolic acid (o,p′-DPA) and para-diphenolic acid (p,p′-DPA). Here we describe a kinetic analysis of solvent-free levulinic acid-phenol condensation catalyzed by phosphotungstic acid at temperatures between 70 and 140°C. The reaction appeared to be pseudo-first-order with respect to levulinic acid when the levulinic acid:phenol molar ratio was four or higher. We determined the kinetic parameters (reaction rate constants, pre-exponential factors, and activation energies) by fitting experimental results to simulated data. Although the activation energies of o,p′-DPA, and p,p′-DPA formation were higher than their corresponding reverse reactions, the kinetic analyses revealed that a steric effect controls the reaction products. Our findings demonstrated a simple temperature-controlled strategy to achieve a p,p′:o,p′ DPA molar ratio of 28.3 with 87% conversion and 98% selectivity to total DPA. This work provides a potential production route for p,p′-DPA from biomass.

Thiol-promoted catalytic synthesis of diphenolic acid with sulfonated hyperbranched poly(arylene oxindole)s

Van De Vyver, Stijn,Geboers, Jan,Helsen, Sasja,Yu, Feng,Thomas, Joice,Smet, Mario,Dehaen, Wim,Sels, Bert F.

scheme or table, p. 3497 - 3499 (2012/06/18)

Acid-catalyzed condensation of levulinic acid and phenol into high yields of diphenolic acid (>50%) is possible with a combination of sulfonated hyperbranched polymers and thiol promotors, either added as a physical mixture or bound to the polymer by ion-pairing.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 126-00-1